Preoperative Carfilzomib and Lulizumab based desensitization prolongs graft survival in a sensitized NHP model.

Sensitized patients are difficult to transplant due to pre-formed anti-donor immunity. We have previously reported successful desensitization using carfilzomib and belatacept in a non-human primate (NHP) model. Here we evaluated selective blockade of the co-stimulatory signal (CD28-B7) with Lulizuma...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Kidney Int
Egile Nagusiak: Schroder, Paul M., Schmitz, Robin, Fitch, Zachary W., Ezekian, Brian, Yoon, Janghoon, Choi, Ashley Y., Manook, Miriam, Barbas, Andrew, Leopardi, Frank, Song, Mingqing, Farris, Alton B., Collins, Bradley, Kwun, Jean, Knechtle, Stuart J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785689/
https://ncbi.nlm.nih.gov/pubmed/32898569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2020.08.020
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak